Clinical Study
Use of Electrocautery for Coagulation and Wound Complications in Caesarean Sections
Table 5
Accumulated surgical scar complications* assessed during follow-up, according to the use of electrocautery for hemostasis.
| | Treatment (use of electrocautery) | -value |
RR | Yes | No | | % | | % |
| Any complication prior to discharge | | | | | | | No | 106 | 97.2 | 111 | 100 | 0.1199 | Not calculable | Yes | 3 | 2.8 | 0 | | Any complication up to postpartum days 7–10 | | | | | | | No | 77 | 77.0 | 88 | 84.6 | 0.1667* | 1.50 (0.84–2.60) | Yes | 23 | 23.0 | 16 | 15.4 | Any complication up to postpartum days 30–40 | | | | | | | No | 77 | 77.0 | 78 | 81.3 | 0.5006* | 1.21 (0.69–2.11) | Yes | 23 | 23.0 | 18 | 18.8 |
|
|
includes hematoma, seroma, dehiscence, and signs of infection.
|